UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids

The American journal of cardiology, 2006-08, Vol.98 (4), p.27-33

Davidson, Michael H.

2006

Volltextzugriff (PDF)

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

Journal of the American College of Cardiology, 2014-12, Vol.64 (23), p.2525-2540

2014

Volltextzugriff (PDF)

Diagnosis and treatment of familial hypercholesterolaemia

European heart journal, 2013-04, Vol.34 (13), p.962-971

2013

Volltextzugriff (PDF)

High-density lipoproteins: A consensus statement from the National Lipid Association

Journal of clinical lipidology, 2013-09, Vol.7 (5), p.484-525

2013

Volltextzugriff (PDF)

Therapeutic Lipidology

2nd Edition 2021, 2020

Volltextzugriff (PDF)

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American Society of Nephrology, 2021-01, Vol.32 (1), p.211-222

2021

Volltextzugriff (PDF)

Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

Atherosclerosis, 2008-03, Vol.197 (1), p.12-24

2008

Volltextzugriff (PDF)

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials

Atherosclerosis, 2019-09, Vol.288, p.194-202

2019

Volltextzugriff (PDF)

Cardiovascular Effects of Glucagonlike peptide–1 Agonists

The American journal of cardiology, 2011-08, Vol.108 (3), p.33B-41B

Davidson, Michael H., MD

2011

Volltextzugriff (PDF)

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

Journal of clinical lipidology, 2014, Vol.8 (1), p.94-106

2014

Volltextzugriff (PDF)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9417

2022

Volltextzugriff (PDF)

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

Current atherosclerosis reports, 2024-02, Vol.26 (2), p.35-44

2024

Volltextzugriff (PDF)

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

Endocrine practice, 2013-05, Vol.19 (3), p.536-557

2013

Volltextzugriff (PDF)

Safety Considerations with Fibrate Therapy

The American journal of cardiology, 2007-03, Vol.99 (6), p.S3-S18

2007

Volltextzugriff (PDF)

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

Journal of the American College of Cardiology, 2013-09, Vol.62 (13), p.1154-1162

2013

Volltextzugriff (PDF)

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

Clinical therapeutics, 2007-07, Vol.29 (7), p.1354-1367

2007

Volltextzugriff (PDF)

Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task Force

The American journal of cardiology, 2006-04, Vol.97 (8), p.S89-S94

2006

Volltextzugriff (PDF)

Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?

Clinical cardiology (Mahwah, N.J.), 2009-09, Vol.32 (9), p.482-486

Davidson, Michael H.

2009

Volltextzugriff (PDF)

The future of n-3 polyunsaturated fatty acid therapy

Current opinion in lipidology, 2016-12, Vol.27 (6), p.570-578

2016

Volltextzugriff (PDF)

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)

The American journal of cardiology, 2003-07, Vol.92 (2), p.152-160

2003

Volltextzugriff (PDF)

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

Journal of clinical lipidology, 2023-07, Vol.17 (4), p.491-503

2023

Volltextzugriff (PDF)

Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis

Alzheimer's research & therapy, 2024-10, Vol.16 (1), p.228-9, Article 228

2024

Volltextzugriff (PDF)

Cardiovascular Risk Factors in a Patient with Diabetes Mellitus and Coronary Artery Disease: Therapeutic Approaches to Improve Outcomes: Perspectives of a Preventive Cardiologist

The American journal of cardiology, 2012-11, Vol.110 (9), p.43B-49B

Davidson, Michael H., MD

2012

Volltextzugriff (PDF)

Safety of Aggressive Lipid Management

Journal of the American College of Cardiology, 2007-05, Vol.49 (17), p.1753-1762

2007

Volltextzugriff (PDF)

Overcoming toxicity and side-effects of lipid-lowering therapies

Baillière's best practice & research. Clinical endocrinology & metabolism, 2014-06, Vol.28 (3), p.439-452

2014

Volltextzugriff (PDF)

1 – 25 von 1.864

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.659)
Mit Volltextzugriff
(1.475)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.244)
Life Sciences & Biomedicine
(1.120)
Humans
(987)
Female
(529)
Male
(498)
Biological And Medical Sciences
(410)
Medical Sciences
(345)
Middle Aged
(344)
Adult
(283)
Aged
(272)
General & Internal Medicine
(225)
Medicine, General & Internal
(219)
Cardiovascular System & Cardiology
(218)
Risk Factors
(209)
Animals
(203)
Cardiac & Cardiovascular Systems
(187)
Treatment Outcome
(151)
Double-Blind Method
(132)
Cardiovascular Disease
(130)
Cardiovascular
(124)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.114)
EZB Electronic Journals Library
(867)
Journals@Ovid
(855)
IngentaConnect Journals
(754)
Publisher or Other Site
(665)
Elsevier ScienceDirect Journals Complete
(494)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(281)
IngentaConnect Journals
(204)
Wiley Online Library
(148)
Oxford Journals Online Current
(113)
Springer Journals
(103)
Ebook Central Perpetual and DDA
(100)
eBooks on EBSCOhost
(100)
Oxford Journals 2020 Medicine
(100)
Jstor Complete Legacy
(91)
Nature Journals
(84)
Wiley Online Library
(78)
Taylor & Francis Journals
(74)
Taylor & Francis
(73)
Taylor & Francis Journals Complete
(71)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

Diagnosis and treatment of familial hypercholesterolaemia

High-density lipoproteins: A consensus statement from the National Lipid Association

Therapeutic Lipidology

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials

Cardiovascular Effects of Glucagonlike peptide–1 Agonists

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

Safety Considerations with Fibrate Therapy

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task Force

Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?

The future of n-3 polyunsaturated fatty acid therapy

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis

Cardiovascular Risk Factors in a Patient with Diabetes Mellitus and Coronary Artery Disease: Therapeutic Approaches to Improve Outcomes: Perspectives of a Preventive Cardiologist

Safety of Aggressive Lipid Management

Overcoming toxicity and side-effects of lipid-lowering therapies

Suchergebnisse filtern